Melicope lunu-ankenda
Melicope lunu-ankenda · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Melicope lunu-ankenda is a significant botanical species known for its diverse therapeutic potential in various medicinal applications. Research focusing on its dried leaves and flowers has revealed potent antidiabetic, antioxidant, and cytotoxic activities. Through the preparation of crude extracts and methanol leaf extracts, specific bioactive chemicals such as Buchapine, GA, Isorhamnetin, and Melicarpinone have been identified. These compounds demonstrate promising efficacy in addressing complex health conditions, including Diabetes Mellitus and lipid metabolism issues. Furthermore, studies involving CH2Cl2-MeOH extracts suggest that the plant holds substantial value in the targeted treatment of breast and colon cancers.
- Synonyms
- Euodia Lunu-Ankenda · Euodia Lunu-Ankenda Var. Tirunelvelica · 17 more
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Flower
Classification
Common Names
Melicope lunu-ankenda is a botanical species recognized by various distinct names across different linguistic traditions. In certain regions, it is frequently referred to by its common name, melikopa voňavá. Its identity is also clearly established in Chinese contexts through the name 三刈叶蜜茱萸. These diverse naming conventions highlight the plant's widespread cultural and geographical presence. Understanding these linguistic relationships helps researchers and enthusiasts identify the species regardless of the local dialect used.
Sources: Catalogue of Life (COL)
Synonyms
Melicope lunu-ankenda is a botanical species characterized by a complex history of taxonomic classifications. Throughout various studies, it has been identified by several different scientific names, including the synonyms Ampacus aromatica and Ampacus roxburghiana. The plant is also closely associated with the genus Euodia, having been referred to as Euodia arborea and Euodia arborescens in previous literature. Furthermore, the name Euodia concinna has been used to describe the same organism in certain botanical contexts. Understanding these shifting relationships is essential for maintaining accurate records within plant taxonomy.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Melicope lunu-ankenda is a fascinating biological specimen belonging to the diverse kingdom Plantae. Within this vast kingdom, the plant is specifically classified under the class Equisetopsida. It further belongs to the order Sapindales, showcasing its evolutionary connections to related woody species. As a member of the Rutaceae family, it shares characteristics common to many citrus-related plants. Ultimately, this species is identified by its unique position within the genus Melicope.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Melicope |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Melicope lunu-ankenda exhibits a diverse geographic range that spans both temperate and tropical regions across Asia. Within the temperate zones, this species is notably found throughout China and the Tibet region. Its tropical distribution is equally extensive, covering significant portions of the Indian Subcontinent, including India and Nepal. Furthermore, the plant flourishes in specific ecological niches such as Assam and the East Himalaya. This wide-reaching presence highlights the adaptability of the species across varied Asian landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Melicope lunu-ankenda is a self-supporting plant characterized by its distinct tree growth form. This species can reach impressive dimensions within its natural habitat. Depending on environmental conditions, it typically achieves a maximum height of 20 m. In certain ideal circumstances, the tree may grow even taller, reaching up to 22 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Melicope lunu-ankenda is emerging as a highly promising medicinal plant due to its diverse range of therapeutic activities. Research indicates that its leaf extracts possess potent antioxidant properties, demonstrated through significant DPPH radical scavenging activity. Furthermore, the plant exhibits strong antidiabetic effects by inhibiting the α-glucosidase enzyme and effectively suppressing fasting blood glucose levels in vivo. Beyond metabolic benefits, the plant also demonstrates remarkable cytotoxic activity, particularly through compounds like 7-geranyloxycinnamic acid which can induce apoptosis in breast cancer cell lines. These multifaceted biological properties suggest that the species could serve as a vital foundation for developing new functional foods and targeted cancer therapies.
Compounds
Melicope lunu-ankenda is a promising medicinal plant recognized for its diverse bioactive profile and significant therapeutic potential. Extensive metabolite profiling has revealed that the plant contains several key compounds, including isorhamnetin, skimmianine, and melicarpinone. Furthermore, research highlights the presence of the O-prenylated flavonoid known as OPF, which plays a crucial role in its antidiabetic properties. While related species like Euodia roxburghiana are noted for containing buchapine, the specific chemical makeup of Melicope lunu-ankenda distinguishes it as a potent source of natural health agents. These findings support the use of the plant in the development of new generation antidiabetic drugs and functional foods.
Conditions
Melicope lunu-ankenda demonstrates significant therapeutic potential by treating breast cancer and colon cancer through the induction of apoptotic pathways. Specifically, the isolated compound 7-geranyloxycinnamic acid exerts potent cytotoxic effects against breast cancer cell lines, including MCF-7. Furthermore, the plant serves as an effective treatment for diabetes mellitus by inhibiting the α-glucosidase enzyme and suppressing fasting blood glucose levels. In vivo studies have confirmed its ability to treat HFD/STZ induced diabetic rats by increasing insulin sensitivity and improving lipid metabolism. These diverse biological activities highlight the plant's capacity to manage both oncological and metabolic disorders.
Preparations
Melicope lunu-ankenda is prepared as dried leaves and dried leaf powder to facilitate the creation of various substances. From these leaves, researchers have produced several crude extracts using solvents of increasing polarity. Specifically, a petroleum ether extract was utilized to isolate the compound 7-geranyloxycinnamic acid. Additionally, the plant is prepared as methanol leaf extracts and as a CH2Cl2-MeOH extract for scientific study. These diverse preparation methods allow for the investigation of the plant's cytotoxic effects on various cancer cell lines.
Parts used
Melicope lunu-ankenda is a medicinal plant belonging to the Rutaceae family that is highly valued in folklore practices across India and Malaysia. The plant's various parts, specifically its leaves and flowers, are recognized for providing significant health benefits. Research has focused heavily on the leaf extracts, which demonstrate potent antidiabetic and antioxidant properties. Studies show that bioactive compounds isolated from these leaves can effectively lower blood glucose levels and improve insulin sensitivity. Consequently, this species holds great promise for the development of new functional foods and next-generation treatments for type 2 diabetes.